Inhibitory effects of levetiracetam on absence seizures in a novel absence-like epilepsy animal model, Groggy rat

Brain Research

Volumn 1359, Issue , 2010, Pages 298-303

  Tokuda, Satoko ^a,d   Sofue, Nobumasa ^b   Ohno, Yukihiro ^b   Sasa, Masashi ^c   Serikawa, Tadao ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c Nagisa Hospital   (Japan)

^d JACKSON LABORATORY   (United States)

Author keywords

Absence seizures; An animal model; Antiepileptic drug; GRY rats; Levetiracetam

Indexed keywords

ETIRACETAM; VALPROIC ACID;

ABSENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG POTENCY; EPILEPTIC DISCHARGE; GENETIC MODEL; GROGGY RAT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SPIKE WAVE; TIME;

ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EPILEPSY, ABSENCE; PIRACETAM; RATS; RATS, MUTANT STRAINS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 77957988501     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.08.084     Document Type: Article

References (28)

1. M. Bialer, R.E. Twyman, and H.S. White Correlation analysis between anticonvulsant ED50 values of antiepileptic drugs in mice and rats and their therapeutic doses and plasma levels Epilepsy Behav. 5 2004 866 872
2. B.M. Bouwman, and C.M. van Rijn Effects of levetiracetam on spike and wave discharges in WAG/Rij rats Seizure 13 2004 591 594
3. J. Cavitt, and M. Privitera Levetiracetam induces a rapid and sustained reduction of generalized spike-wave and clinical absence Arch. Neurol. 61 2004 1604 1607
4. T. De Smedt, R. Raedt, K. Vonck, and P. Boon Levetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data CNS Drug Rev. 13 2007 43 56
5. S. Dedeurwaerdere, P. Boon, T. De Smedt, P. Claeys, R. Raedt, T. Bosman, P. Van Hese, G. Van Maele, and K. Vonck Chronic levetiracetam treatment early in life decreases epileptiform events in young GAERS, but does not prevent the expression of spike and wave discharges during adulthood Seizure 14 2005 403 411
6. C. Di Bonaventura, J. Fattouch, F. Mari, G. Egeo, A.E. Vaudano, M. Prencipe, M. Manfredi, and A.T. Giallonardo Clinical experience with levetiracetam in idiopathic generalized epilepsy according to different syndrome subtypes Epileptic Disord. 7 2005 231 235
7. H.C. Doheny, N. Ratnaraj, M.A. Whittington, J.G. Jefferys, and P.N. Patsalos Blood and cerebrospinal fluid pharmacokinetics of the novel anticonvulsant levetiracetam (ucb L059) in the rat Epilepsy Res. 34 1999 161 168
8. C.F. Fletcher, C.M. Lutz, T.N. O'Sullivan, J.D. Shaughnessy Jr., R. Hawkes, W.N. Frankel, N.G. Copeland, and N.A. Jenkins Absence epilepsy in tottering mutant mice is associated with calcium channel defects Cell 87 1996 607 617
9. A.J. Gower, M. Noyer, R. Verloes, J. Gobert, and E. Wulfert ucb L059, a novel anti-convulsant drug: pharmacological profile in animals Eur. J. Pharmacol. 222 1992 193 203
10. A.J. Gower, E. Hirsch, A. Boehrer, M. Noyer, and C. Marescaux Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy Epilepsy Res. 22 1995 207 213
11. C. Ji-qun, K. Ishihara, T. Nagayama, T. Serikawa, and M. Sasa Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs Epilepsia 46 2005 1362 1370
12. S.I. Johannessen, D. Battino, D.J. Berry, M. Bialer, G. Kramer, T. Tomson, and P.N. Patsalos Therapeutic drug monitoring of the newer antiepileptic drugs Ther. Drug Monit. 25 2003 347 363
13. R.M. Kaminski, A. Matagne, K. Leclercq, M. Gillard, P. Michel, B. Kenda, P. Talaga, and H. Klitgaard SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy Neuropharmacology 54 2008 715 720
14. R.M. Kaminski, M. Gillard, K. Leclercq, E. Hanon, G. Lorent, D. Dassesse, A. Matagne, and H. Klitgaard Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam Epilepsia 2009
15. H. Klitgaard Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? Epilepsia 42 Suppl 4 2001 13 18
16. H. Klitgaard, A. Matagne, J. Gobert, and E. Wulfert Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy Eur. J. Pharmacol. 353 1998 191 206
17. W. Loscher, and D. Honack Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats Eur. J. Pharmacol. 232 1993 147 158
18. B.A. Lynch, N. Lambeng, K. Nocka, P. Kensel-Hammes, S.M. Bajjalieh, A. Matagne, and B. Fuks The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam Proc. Natl. Acad. Sci. U. S. A. 101 2004 9861 9866
19. F. Marrosu, M. Bortolato, R. Frau, M. Orru, M. Puligheddu, M. Fa, A. Muroni, A. Tuveri, and G. Mereu Levetiracetam attenuates spontaneous spike-and-wave discharges in DBA/2J mice Epilepsy Res. 75 2007 224 227
20. E. Mesdjian, L. Ciesielski, M. Valli, B. Bruguerolle, G. Jadot, P. Bouyard, and P. Mandel Sodium valproate: kinetic profile and effects on GABA levels in various brain areas of the rat Prog. Neuropsychopharmacol. Biol. Psychiatry 6 1982 223 233 (Pubitemid 13199919)
21. Y. Ohno, S. Ishihara, R. Terada, T. Serikawa, and M. Sasa Antiepileptogenic and anticonvulsive actions of levetiracetam in a pentylenetetrazole kindling model Epilepsy Res. 89 2010 360 364
22. E. Russo, R. Citraro, F. Scicchitano, S. De Fazio, E.D. Di Paola, A. Constanti, and G. De Sarro Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy Epilepsia 2009
23. M. Sasa A new frontier in epilepsy: novel antiepileptogenic drugs J. Pharmacol. Sci. 100 2006 487 494
24. P. Striano, V. Sofia, G. Capovilla, G. Rubboli, C. Di Bonaventura, A. Coppola, G. Vitale, L. Fontanillas, A.T. Giallonardo, R. Biondi, A. Romeo, M. Viri, F. Zara, and S. Striano A pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome) Epilepsia 49 2008 425 430
25. I.K. Takeuchi, E. Aoki, and Y.K. Takeuchi Age-related and region-specific increase in number of concentric lamellar bodies in axon terminals and presynaptic axons in central nervous system of groggy mutant rat Acta Neuropathol. 87 1994 628 634
26. S. Tokuda, T. Kuramoto, K. Tanaka, S. Kaneko, I.K. Takeuchi, M. Sasa, and T. Serikawa The ataxic groggy rat has a missense mutation in the P/Q-type voltage-gated Ca2+ channel alpha1A subunit gene and exhibits absence seizures Brain Res. 1133 2007 168 177
27. A. Verrotti, C. Cerminara, S. Domizio, A. Mohn, E. Franzoni, G. Coppola, N. Zamponi, P. Parisi, P. Iannetti, and P. Curatolo Levetiracetam in absence epilepsy Dev. Med. Child Neurol. 50 2008 850 853
28. H.D. Yan, C. Ji-qun, K. Ishihara, T. Nagayama, T. Serikawa, and M. Sasa Separation of antiepileptogenic and antiseizure effects of levetiracetam in the spontaneously epileptic rat (SER) Epilepsia 46 2005 1170 1177